are tirzepatide and zepbound the same Which Weight-Loss Drug Is Better: Wegovy or Zepbound? Tirzepatide vs Zepbound - NowPatient

Sources Eli Lilly, "Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial" (May 21, 2026) TRIUMPH-1 topline: 28.3% at 80 weeks, 30.3% at 104 weeks, 45.3% achieving 30%+ weight loss Eli Lilly, "Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials" (July 23, 2026) TRIUMPH-2 (20.8% at 12 mg, A1C up to -1.6%) and TRIUMPH-3 (22.6% at 12 mg) topline, plus the stated plan to submit a BLA to the FDA in Q1 2027 ClinicalTrials.gov NCT05929066 (TRIUMPH-1) Phase 3, status Completed, primary completion April 6, 2026 Eli Lilly Q4 2025 earnings call transcript (February 4, 2026) confirmed regulatory submission planned for 2026 Eli Lilly press releases and investor communications ClinicalTrials.gov (TRIUMPH program trial registrations) Jastreboff AM, et al

Start With a Provider-Led GLP-1 Program If you are ready to explore medically supervised weight-loss care, Independent Wellness makes it easy to begin

Hair loss during treatment usually reflects the body adapting to rapid change, not drug toxicity

Long-term side effects from Wegovy are still being researched and will vary depending on the user and their existing medical conditions

Chronic elevation of SUA level leads to the formation and deposition of monosodium urate (MSU) crystals leads to inflammatory reaction and tissue injury in many organs such as joint, kidney, and heart ( Hyperuricaemia-Related Diseases Gout Strong epidemiological evidence demonstrates that the prevalence of gout is growing worldwide

These functions are primarily mediated through the melanocortin receptors (MCRs) in various tissues [2]